Official Title
The Nanowear Wearable Covid-19 Observational and Analysis Trend
Brief Summary

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Recruiting
COVID19

Device: Observational Study - no intervention

Observational Study - no intervention

Eligibility Criteria

Inclusion Criteria:

- Subject has provided informed consent

- Male or female over the age of 18 years

- The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion Criteria:

- Subject is unwilling or unable to wear the vest during hospitalization.

- Subjects who are pregnant.

- Subject is intubated or admitted to ICU

- Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter
defibrillator)

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Hackensack University Medical Center
Hackensack, New Jersey, United States

Maimonides Medical Center
Brooklyn, New York, United States

Nanowear Inc.
NCT Number
MeSH Terms
COVID-19